Personal tools

MCL coexpression mm9:1124: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000077!1.06e-20!35;UBERON:0002193!2.23e-19!48;UBERON:0002405!2.23e-19!48;UBERON:0004177!2.95e-19!29;UBERON:0005057!2.95e-19!29;UBERON:0002390!4.85e-19!45;UBERON:0003061!4.85e-19!45;UBERON:0002370!2.29e-15!23;UBERON:0000974!2.29e-15!23;UBERON:0004807!2.29e-15!23;UBERON:0005058!2.29e-15!23;UBERON:0003351!2.29e-15!23;UBERON:0009113!2.29e-15!23;UBERON:0003295!2.29e-15!23;UBERON:0009722!2.29e-15!23;UBERON:0005562!2.29e-15!23;UBERON:0007690!2.29e-15!23;UBERON:0000065!7.34e-15!41;UBERON:0006562!1.46e-14!24;UBERON:0003408!1.46e-14!24;UBERON:0001557!1.46e-14!24;UBERON:0001042!1.46e-14!24;UBERON:0008814!1.46e-14!24;UBERON:0009145!1.46e-14!24;UBERON:0001004!2.24e-14!42;UBERON:0000072!1.64e-12!27;UBERON:0001041!3.71e-11!80;UBERON:0003081!3.88e-10!87;UBERON:0000063!4.07e-10!35;UBERON:0005911!2.17e-09!69;UBERON:0007811!1.90e-08!36;UBERON:0000926!4.42e-08!120;UBERON:0004120!4.42e-08!120;UBERON:0006603!4.42e-08!120;UBERON:0004119!4.50e-08!118;UBERON:0000925!4.50e-08!118;UBERON:0006595!4.50e-08!118;UBERON:0004921!7.34e-08!114;UBERON:0001007!1.34e-07!116;UBERON:0001555!1.34e-07!116;UBERON:0007026!1.34e-07!116
|ontology_enrichment_uberon=UBERON:0000077!1.06e-20!35;UBERON:0002193!2.23e-19!48;UBERON:0002405!2.23e-19!48;UBERON:0004177!2.95e-19!29;UBERON:0005057!2.95e-19!29;UBERON:0002390!4.85e-19!45;UBERON:0003061!4.85e-19!45;UBERON:0002370!2.29e-15!23;UBERON:0000974!2.29e-15!23;UBERON:0004807!2.29e-15!23;UBERON:0005058!2.29e-15!23;UBERON:0003351!2.29e-15!23;UBERON:0009113!2.29e-15!23;UBERON:0003295!2.29e-15!23;UBERON:0009722!2.29e-15!23;UBERON:0005562!2.29e-15!23;UBERON:0007690!2.29e-15!23;UBERON:0000065!7.34e-15!41;UBERON:0006562!1.46e-14!24;UBERON:0003408!1.46e-14!24;UBERON:0001557!1.46e-14!24;UBERON:0001042!1.46e-14!24;UBERON:0008814!1.46e-14!24;UBERON:0009145!1.46e-14!24;UBERON:0001004!2.24e-14!42;UBERON:0000072!1.64e-12!27;UBERON:0001041!3.71e-11!80;UBERON:0003081!3.88e-10!87;UBERON:0000063!4.07e-10!35;UBERON:0005911!2.17e-09!69;UBERON:0007811!1.90e-08!36;UBERON:0000926!4.42e-08!120;UBERON:0004120!4.42e-08!120;UBERON:0006603!4.42e-08!120;UBERON:0004119!4.50e-08!118;UBERON:0000925!4.50e-08!118;UBERON:0006595!4.50e-08!118;UBERON:0004921!7.34e-08!114;UBERON:0001007!1.34e-07!116;UBERON:0001555!1.34e-07!116;UBERON:0007026!1.34e-07!116
|tfbs_overrepresentation_for_novel_motifs=0.438063,0.0418382,0.411716,0.480627,0.810002,0.495263,0.587291,0.206208,0.215218,0.0609112,0.542749,0.575086,0.206435,0.599731,0.315771,0,0.795315,0.291368,0.561256,0.361892,0.978328,0.08187,0.598814,0.29769,0.419327,0.62766,0.542568,0.516511,0.344372,0.145661,0.50223,0.897561,0.289148,0.166577,0.316253,0.101236,0.279977,0.57142,0.717242,0.230656,0.295233,0.507468,0.258106,3.23003,0.0275764,0.469348,0.714592,0.532496,0.219744,0.347313,0.777641,0.654933,0.139618,1.04034,1.0579,0.606984,0.356236,0.56214,0.176152,0.604914,0.877332,0.664501,0.226529,0.766235,0.618279,0.807219,1.19497,1.54543,0.872612,1.39786,0.392734,0.608073,0.0869413,1.09164,0.17012,0.159969,0.166511,0.703064,0.859987,2.6336,0.212973,0.812889,1.59309,1.72681,0.975495,0.0369809,0.374181,0.447265,0.719558,1.70793,1.26498,0.980512,0.910485,0.305079,0.254625,0.237542,0.203879,0.913319,0.71485,0.127063,0.280055,0.897279,1.02279,0.778243,0.777175,0.507021,0.837607,0.528416,0.383871,0.376549,0.430942,1.02459,0.990132,0.547992,1.27206,0.293461,0.0501572,0.484437,0.796633,0.276329,1.09707,0.745011,0.629509,0.702145,1.32639,0.863723,0.595563,0.903645,1.19345,0.308038,2.29762,0.473246,1.16374,0.620831,1.29374,0.580299,0.446555,0.508896,2.78138,2.07659,1.67603,1.19971,0.641722,0.908128,0.770616,0.507927,0.717753,2.03691,1.13988,0.300961,0.452587,0.0736236,1.04192,0.243291,0.619892,4.12533,0.655955,0.327731,1.11101,0.446272,1.25393,3.66612,0.864173,0.428662,3.02053,0.612377,0.278874,0.573477,0.0206035
}}
}}

Revision as of 19:25, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:91624165..91624180,+p@chr13:91624165..91624180
+
Mm9::chr17:52288610..52288620,+p@chr17:52288610..52288620
+
Mm9::chr17:52288630..52288664,+p@chr17:52288630..52288664
+
Mm9::chr1:175529374..175529408,-p1@Pydc4
Mm9::chr1:175603782..175603817,+p1@Pydc3
Mm9::chr1:175603833..175603841,+p4@Pydc3
Mm9::chr1:175604032..175604047,+p2@Pydc3


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
mixed endoderm/mesoderm-derived structure1.06e-2035
hemolymphoid system2.23e-1948
immune system2.23e-1948
hemopoietic organ2.95e-1929
immune organ2.95e-1929
hematopoietic system4.85e-1945
blood island4.85e-1945
thymus2.29e-1523
neck2.29e-1523
respiratory system epithelium2.29e-1523
hemolymphoid system gland2.29e-1523
pharyngeal epithelium2.29e-1523
thymic region2.29e-1523
pharyngeal gland2.29e-1523
entire pharyngeal arch endoderm2.29e-1523
thymus primordium2.29e-1523
early pharyngeal endoderm2.29e-1523
respiratory tract7.34e-1541
pharynx1.46e-1424
gland of gut1.46e-1424
upper respiratory tract1.46e-1424
chordate pharynx1.46e-1424
pharyngeal arch system1.46e-1424
pharyngeal region of foregut1.46e-1424
respiratory system2.24e-1442
segment of respiratory tract1.64e-1227
foregut3.71e-1180
lateral plate mesoderm3.88e-1087
organ segment4.07e-1035
endo-epithelium2.17e-0969
craniocervical region1.90e-0836
mesoderm4.42e-08120
mesoderm-derived structure4.42e-08120
presumptive mesoderm4.42e-08120
endoderm-derived structure4.50e-08118
endoderm4.50e-08118
presumptive endoderm4.50e-08118
subdivision of digestive tract7.34e-08114
digestive system1.34e-07116
digestive tract1.34e-07116
primitive gut1.34e-07116


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:1124&oldid=2562344"